168 related articles for article (PubMed ID: 32348940)
1. Protein ligand interaction analysis against new CaMKK2 inhibitors by use of X-ray crystallography and the fragment molecular orbital (FMO) method.
Takaya D; Niwa H; Mikuni J; Nakamura K; Handa N; Tanaka A; Yokoyama S; Honma T
J Mol Graph Model; 2020 Sep; 99():107599. PubMed ID: 32348940
[TBL] [Abstract][Full Text] [Related]
2. Protein-ligand binding affinity prediction of cyclin-dependent kinase-2 inhibitors by dynamically averaged fragment molecular orbital-based interaction energy.
Takaba K; Watanabe C; Tokuhisa A; Akinaga Y; Ma B; Kanada R; Araki M; Okuno Y; Kawashima Y; Moriwaki H; Kawashita N; Honma T; Fukuzawa K; Tanaka S
J Comput Chem; 2022 Jul; 43(20):1362-1371. PubMed ID: 35678372
[TBL] [Abstract][Full Text] [Related]
3. CaMKK2 kinase domain interacts with the autoinhibitory region through the N-terminal lobe including the RP insert.
Kylarova S; Psenakova K; Herman P; Obsilova V; Obsil T
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2304-2313. PubMed ID: 30053538
[TBL] [Abstract][Full Text] [Related]
4. Prediction of cyclin-dependent kinase 2 inhibitor potency using the fragment molecular orbital method.
Mazanetz MP; Ichihara O; Law RJ; Whittaker M
J Cheminform; 2011 Jan; 3(1):2. PubMed ID: 21219630
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3 protein directly interacts with the kinase domain of calcium/calmodulin-dependent protein kinase kinase (CaMKK2).
Psenakova K; Petrvalska O; Kylarova S; Lentini Santo D; Kalabova D; Herman P; Obsilova V; Obsil T
Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1612-1625. PubMed ID: 29649512
[TBL] [Abstract][Full Text] [Related]
6. Theoretical Analysis of Activity Cliffs among Benzofuranone-Class Pim1 Inhibitors Using the Fragment Molecular Orbital Method with Molecular Mechanics Poisson-Boltzmann Surface Area (FMO+MM-PBSA) Approach.
Watanabe C; Watanabe H; Fukuzawa K; Parker LJ; Okiyama Y; Yuki H; Yokoyama S; Nakano H; Tanaka S; Honma T
J Chem Inf Model; 2017 Dec; 57(12):2996-3010. PubMed ID: 29111719
[TBL] [Abstract][Full Text] [Related]
7. Analyzing GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
Heifetz A; James T; Southey M; Morao I; Fedorov DG; Bodkin MJ; Townsend-Nicholson A
Methods Mol Biol; 2020; 2114():163-175. PubMed ID: 32016893
[TBL] [Abstract][Full Text] [Related]
8. Exploring GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
Chudyk EI; Sarrat L; Aldeghi M; Fedorov DG; Bodkin MJ; James T; Southey M; Robinson R; Morao I; Heifetz A
Methods Mol Biol; 2018; 1705():179-195. PubMed ID: 29188563
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of Protein-Protein Interactions between CaMKK2 and 14-3-3 by Fusicoccins.
Lentini Santo D; Petrvalska O; Obsilova V; Ottmann C; Obsil T
ACS Chem Biol; 2020 Nov; 15(11):3060-3071. PubMed ID: 33146997
[TBL] [Abstract][Full Text] [Related]
10. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
[TBL] [Abstract][Full Text] [Related]
11. Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes.
Eduful BJ; O'Byrne SN; Temme L; Asquith CRM; Liang Y; Picado A; Pilotte JR; Hossain MA; Wells CI; Zuercher WJ; Catta-Preta CMC; Zonzini Ramos P; Santiago AS; Couñago RM; Langendorf CG; Nay K; Oakhill JS; Pulliam TL; Lin C; Awad D; Willson TM; Frigo DE; Scott JW; Drewry DH
J Med Chem; 2021 Aug; 64(15):10849-10877. PubMed ID: 34264658
[TBL] [Abstract][Full Text] [Related]
12. 14-3-3 protein inhibits CaMKK1 by blocking the kinase active site with its last two C-terminal helices.
Petrvalska O; Honzejkova K; Koupilova N; Herman P; Obsilova V; Obsil T
Protein Sci; 2023 Nov; 32(11):e4805. PubMed ID: 37817008
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase A negatively regulates VEGF-induced AMPK activation by phosphorylating CaMKK2 at serine 495.
Spengler K; Zibrova D; Woods A; Langendorf CG; Scott JW; Carling D; Heller R
Biochem J; 2020 Sep; 477(17):3453-3469. PubMed ID: 32869834
[TBL] [Abstract][Full Text] [Related]
14. Towards good correlation between fragment molecular orbital interaction energies and experimental IC
Sheng Y; Watanabe H; Maruyama K; Watanabe C; Okiyama Y; Honma T; Fukuzawa K; Tanaka S
Comput Struct Biotechnol J; 2018; 16():421-434. PubMed ID: 30450166
[TBL] [Abstract][Full Text] [Related]
15. Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) inhibitors: a novel approach in small molecule discovery.
Devasahayam Arokia Balaya R; Chandrasekaran J; Kanekar S; Kumar Modi P; Dagamajalu S; Gopinathan K; Raju R; Prasad TSK
J Biomol Struct Dyn; 2023; 41(24):15196-15206. PubMed ID: 37029757
[TBL] [Abstract][Full Text] [Related]
16. Using the fluorescent properties of STO-609 as a tool to assist structure-function analyses of recombinant CaMKK2.
Gerner L; Munack S; Temmerman K; Lawrence-Dörner AM; Besir H; Wilmanns M; Jensen JK; Thiede B; Mills IG; Morth JP
Biochem Biophys Res Commun; 2016 Jul; 476(2):102-7. PubMed ID: 27178209
[TBL] [Abstract][Full Text] [Related]
17. The role of CaMKK2 in Golgi-associated vesicle trafficking.
Kennedy G; Gibson O; T O'Hare D; Mills IG; Evergren E
Biochem Soc Trans; 2023 Feb; 51(1):331-342. PubMed ID: 36815702
[TBL] [Abstract][Full Text] [Related]
18. CaMKK2 is inactivated by cAMP-PKA signaling and 14-3-3 adaptor proteins.
Langendorf CG; O'Brien MT; Ngoei KRW; McAloon LM; Dhagat U; Hoque A; Ling NXY; Dite TA; Galic S; Loh K; Parker MW; Oakhill JS; Kemp BE; Scott JW
J Biol Chem; 2020 Nov; 295(48):16239-16250. PubMed ID: 32913128
[TBL] [Abstract][Full Text] [Related]
19. Assessment and acceleration of binding energy calculations for protein-ligand complexes by the fragment molecular orbital method.
Otsuka T; Okimoto N; Taiji M
J Comput Chem; 2015 Nov; 36(30):2209-18. PubMed ID: 26400829
[TBL] [Abstract][Full Text] [Related]
20. Impact of Genetic Variation on Human CaMKK2 Regulation by Ca
O'Brien MT; Oakhill JS; Ling NX; Langendorf CG; Hoque A; Dite TA; Means AR; Kemp BE; Scott JW
Sci Rep; 2017 Feb; 7():43264. PubMed ID: 28230171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
